Albiglutide
Status unknownAlso known as: albiglutidum, Albiglutida, RefChem:141, A10BJ04, Albiglutide (genetical recombination), 5E7U48495E, 782500-75-8, Eperzan
Albiglutide (albiglutidum, Albiglutida, RefChem:141) is classified under glp-1 & incretin agonists.
Independent test grades
No independent third-party test data is available for Albiglutide yet. Our test grades are aggregated from Finnrick, which independently tests a subset of research peptides — many approved drugs and newer or niche compounds aren't covered.
Research literature (8)
Consolidated from PubMed — each links to the original record.
- Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis.
Kamrul-Hasan ABM, Dutta D, Nagendra L, Bhattacharya S, Singla R, Kalra S · Medicine · 2024 · PMID 38905435
- GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Kapoor I, Sarvepalli SM, D'Alessio D, Grewal DS, Hadziahmetovic M · Survey of ophthalmology · 2023 · PMID 37454782
- GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Nauck MA, Quast DR, Wefers J, Meier JJ · Molecular metabolism · 2021 · PMID 33068776
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D · The lancet. Diabetes & endocrinology · 2019 · PMID 31422062
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP · Lancet (London, England) · 2018 · PMID 30291013
- Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus.
Davis PN, Ndefo UA, Oliver A, Payton E · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2015 · PMID 26092960
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.
Meier JJ · Nature reviews. Endocrinology · 2012 · PMID 22945360
- Albiglutide.
2012 · PMID 31643385
FAQ
- What is Albiglutide?
- Albiglutide (albiglutidum, Albiglutida, RefChem:141) is classified under glp-1 & incretin agonists. Research goals associated with it include metabolic & weight.
- Is Albiglutide FDA-approved?
- The regulatory status of Albiglutide is not established in our sources.
- What does the research on Albiglutide say?
- peptideone aggregates 8 references from PubMed for Albiglutide. The summary on this page digests them with citations; we summarize sources and make no efficacy claims.